glp-1s with compounded semaglutide GLP-1 Care Compounded Semaglutide (GLP-1)

In analysis of TTO based on parameter distributions and the valid cases, the median TTOs (Interquartile range) for SSIBs associated with semaglutide, liraglutide, dulaglutide, and exenatide were 15.5 (0.524.25, n = 18), 9.5 (0.561.5, n = 19), 35.5 (6.560.5, n = 11), and 2.5 (1.5169.5, n = 4) days, respectively (albiglutide was not included in the TTO analysis due to insufficient data)

Neither approach is inherently wrong, but the difference matters depending on what youre looking for

Make sure it's dark in your room, make sure you don't have a lot of lights and flashing things all around you

doi: 10.3390/ijms22041988 [DOI] [PMC free article] [PubMed] [Google Scholar] 2